Session 10. Closing Keynote lecture: What is new in diabetes trials?

Update on relevant Cardio-reno-metabolic trials

  Melanie Davies
  Professor of Diabetes Medicine, University of Leicester

Melanie Davies is Professor of Diabetes Medicine at the University of Leicester and an Honorary Consultant Diabetologist at the University Hospitals of Leicester NHS Trust.  She is the Co-Director of the Leicester Diabetes Centre, University Hospitals of Leicester NHS Trust.

Professor Davies’ research interests include the causes, screening, prevention, self-management and treatment of type 2 diabetes mellitus.  She is a National Institute for Health Research Senior Investigator Emeritus and Director of the NIHR Leicester Biomedical Research Centre and co-chair of EASD/ADA’s Consensus Report on T2DM Management.

Professor Davies has published over 910 original articles and has over £100M of grant funding.  She was awarded the CBE (Commander of the Most Excellent Order of the British Empire) in the 2016 New Year’s Honour’s List for services to diabetes research.

In this presentation there will be a review of the main clinical trials which have reported in the past year relating to Cardio-Renal-Metabolic disease in T2DM. These include long term follow up of the DIRECT trial, SURMOUNT2, SURPASS 6 and the study of Dapagliflozin in children with type 2 diabetes.
We will also cover the phase 2 trials of Cagri-Sema and Retatrutide in type 2 diabetes.